Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
NO-cGMP modulation remains investigational for hypertrophy; leaves open need for trials before any clinical adoption.
George W. Booz (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: